Comparative two-phase clinicopharmacological trial of a new antihistaminic, EGYT-2062, setastine.

@article{Vezeknyi1987ComparativeTC,
  title={Comparative two-phase clinicopharmacological trial of a new antihistaminic, EGYT-2062, setastine.},
  author={Z Vezek{\'e}nyi and K Zolnai and Lajos Nagy},
  journal={Acta medica Hungarica},
  year={1987},
  volume={44 1},
  pages={55-64}
}
During the two-phase clinicopharmacological trial in humans of a new antihistaminic compound EGYT-2062, setastine developed by EGIS Pharmaceutical Company, Budapest, was tested the tolerance to the drug, its pharmacodynamic effect by i. c. histamine and acetylcholine tests, and its effect on the CNS by neuropsychiatric examination on eight healthy… CONTINUE READING